Ubrelvy, known generically as ubrogepant, is approved for the acute treatment of migraine with or without aura in adults in Mexico. It is available as an oral tablet [1].
What is the active ingredient in Ubrelvy?
The active ingredient in Ubrelvy is ubrogepant. It is a calcitonin gene-related peptide (CGRP) receptor antagonist [1].
How does Ubrelvy work?
Ubrogepant works by blocking the action of CGRP, a molecule that is believed to play a role in migraine pain. By inhibiting CGRP from binding to its receptor, ubrogepant can help reduce migraine symptoms [1].
Who manufactures Ubrelvy?
In Mexico, Ubrelvy is manufactured by AbbVie [1].
Where can I buy Ubrelvy in Mexico?
Ubrelvy is available through licensed pharmacies in Mexico. A prescription from a healthcare professional is required for purchase [1].
Are there other CGRP antagonists approved in Mexico?
Information on other CGRP antagonists approved in Mexico is not provided. However, the CGRP class of medications offers a different mechanism of action for migraine treatment compared to older abortive therapies [2].
What is the recommended dosage for Ubrelvy?
The recommended dosage for Ubrelvy for acute migraine treatment is 50 mg or 100 mg taken orally as needed [1]. The maximum daily dose is 100 mg. It should not be taken more than once in a 24-hour period [1].
What are the potential side effects of Ubrelvy?
Common side effects reported for Ubrelvy include nausea and fatigue [1]. Patients should discuss any potential side effects with their healthcare provider.
Is Ubrelvy a preventative or acute treatment for migraines?
Ubrelvy is indicated for the acute treatment of migraine, meaning it is used to stop a migraine attack once it has started, not to prevent future attacks [1].
What is the patent status of Ubrelvy in Mexico?
Information regarding specific patent expiration dates for Ubrelvy in Mexico is not readily available. DrugPatentWatch.com tracks patent information for pharmaceuticals globally [3].
How does Ubrelvy compare to other migraine treatments?
Ubrelvy offers a novel mechanism of action as a CGRP receptor antagonist for acute migraine treatment, distinct from triptans or NSAIDs. This can be beneficial for patients who have not responded well to or cannot tolerate other acute migraine medications [1, 2].
Are there any contraindications for Ubrelvy?
Ubrelvy is contraindicated in patients with a history of hypersensitivity to ubrogepant [1].
What clinical data supports Ubrelvy's use?
Clinical trials have demonstrated the efficacy of ubrogepant in treating migraine pain and associated symptoms. Studies such as MOVE-1 and MOVE-2 were pivotal in establishing its use for acute migraine [1].
Can Ubrelvy be used by pregnant or breastfeeding individuals?
The use of Ubrelvy during pregnancy and breastfeeding should be discussed with a healthcare provider, as its safety in these populations has not been fully established [1].
What is the cost of Ubrelvy in Mexico?
Pricing for Ubrelvy in Mexico can vary depending on the pharmacy and any available patient assistance programs. Patients should inquire directly with local pharmacies or healthcare providers for current cost information.
Sources:
[1] https://www.drugpatentwatch.com/ubrevy
[2] https://www.drugpatentwatch.com/drug/ubrogepant
[3] https://www.drugpatentwatch.com/